The global Drug Eluting Coronary Stent System market size is predicted to grow from US$ 6057 million in 2025 to US$ 8146 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.

Global Drug Eluting Coronary Stent System Market Trends, Growth | CAGR 4.4%

The global Drug Eluting Coronary Stent System market size is predicted to grow from US$ 6057 million in 2025 to US$ 8146 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032. The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects. United States market for Drug Eluting Coronary Stent System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for Drug Eluting Coronary Stent System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for Drug Eluting Coronary Stent System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key Drug Eluting Coronary Stent System players cover Boston Scientific, Medtronic, Abbott, B.Braun, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. Infinity Market Research newest research report, the Drug Eluting Coronary Stent System Industry Forecast looks at past sales and reviews total world Drug Eluting Coronary Stent System sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Eluting Coronary Stent System sales for 2026 through 2032. With Drug Eluting Coronary Stent System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Coronary Stent System industry. This Insight Report provides a comprehensive analysis of the global Drug Eluting Coronary Stent System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Coronary Stent System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Drug Eluting Coronary Stent System market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Coronary Stent System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Coronary Stent System. This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Coronary Stent System market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Rapamycin Eluting Stent &nbsp;&nbsp;&nbsp; Everolimus Eluting Stent &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Boston Scientific &nbsp;&nbsp;&nbsp; Medtronic &nbsp;&nbsp;&nbsp; Abbott &nbsp;&nbsp;&nbsp; B.Braun &nbsp;&nbsp;&nbsp; BD &nbsp;&nbsp;&nbsp; Biotronik AG &nbsp;&nbsp;&nbsp; Stentys SA &nbsp;&nbsp;&nbsp; Sino Medical &nbsp;&nbsp;&nbsp; Beijing ESSEN Technology &nbsp;&nbsp;&nbsp; Beijing Advanced Medical Technologies &nbsp;&nbsp;&nbsp; LifeTech Scientific Corporation &nbsp;&nbsp;&nbsp; MicroPort Scientific Corporation &nbsp;&nbsp;&nbsp; Yilson Medical Technology &nbsp;&nbsp;&nbsp; Lepu Medical Technology &nbsp;&nbsp;&nbsp; Shandong Huaan Biotechnology Key Questions Addressed in this Report What is the 10-year outlook for the global Drug Eluting Coronary Stent System market? What factors are driving Drug Eluting Coronary Stent System market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Drug Eluting Coronary Stent System market opportunities vary by end market size? How does Drug Eluting Coronary Stent System break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Drug Eluting Coronary Stent System Annual Sales 2021-2032 &nbsp;2.1.2 World Current & Future Analysis for Drug Eluting Coronary Stent System by Geographic Region, 2021, 2025 & 2032 &nbsp;2.1.3 World Current & Future Analysis for Drug Eluting Coronary Stent System by Country/Region, 2021, 2025 & 2032 &nbsp;2.2 Drug Eluting Coronary Stent System Segment by Type &nbsp;2.2.1 Rapamycin Eluting Stent &nbsp;2.2.2 Everolimus Eluting Stent &nbsp;2.2.3 Others &nbsp;2.2.4 Drug Eluting Coronary Stent System Sales by Type &nbsp;2.2.4.1 Global Drug Eluting Coronary Stent System Sales Market Share by Type (2021-2026) &nbsp;2.2.4.2 Global Drug Eluting Coronary Stent System Revenue and Market Share by Type (2021-2026) &nbsp;2.2.4.3 Global Drug Eluting Coronary Stent System Sale Price by Type (2021-2026) &nbsp;2.3 Drug Eluting Coronary Stent System Segment by Application &nbsp;2.3.1 Hospitals &nbsp;2.3.2 Clinic &nbsp;2.3.3 Others &nbsp;2.3.4 Drug Eluting Coronary Stent System Sales by Application &nbsp;2.3.4.1 Global Drug Eluting Coronary Stent System Sale Market Share by Application (2021-2026) &nbsp;2.3.4.2 Global Drug Eluting Coronary Stent System Revenue and Market Share by Application (2021-2026) &nbsp;2.3.4.3 Global Drug Eluting Coronary Stent System Sale Price by Application (2021-2026) 3 Global by Company &nbsp;3.1 Global Drug Eluting Coronary Stent System Breakdown Data by Company &nbsp;3.1.1 Global Drug Eluting Coronary Stent System Annual Sales by Company (2021-2026) &nbsp;3.1.2 Global Drug Eluting Coronary Stent System Sales Market Share by Company (2021-2026) &nbsp;3.2 Global Drug Eluting Coronary Stent System Annual Revenue by Company (2021-2026) &nbsp;3.2.1 Global Drug Eluting Coronary Stent System Revenue by Company (2021-2026) &nbsp;3.2.2 Global Drug Eluting Coronary Stent System Revenue Market Share by Company (2021-2026) &nbsp;3.3 Global Drug Eluting Coronary Stent System Sale Price by Company &nbsp;3.4 Key Manufacturers Drug Eluting Coronary Stent System Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Drug Eluting Coronary Stent System Product Location Distribution &nbsp;3.4.2 Players Drug Eluting Coronary Stent System Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Drug Eluting Coronary Stent System by Geographic Region &nbsp;4.1 World Historic Drug Eluting Coronary Stent System Market Size by Geographic Region (2021-2026) &nbsp;4.1.1 Global Drug Eluting Coronary Stent System Annual Sales by Geographic Region (2021-2026) &nbsp;4.1.2 Global Drug Eluting Coronary Stent System Annual Revenue by Geographic Region (2021-2026) &nbsp;4.2 World Historic Drug Eluting Coronary Stent System Market Size by Country/Region (2021-2026) &nbsp;4.2.1 Global Drug Eluting Coronary Stent System Annual Sales by Country/Region (2021-2026) &nbsp;4.2.2 Global Drug Eluting Coronary Stent System Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas Drug Eluting Coronary Stent System Sales Growth &nbsp;4.4 APAC Drug Eluting Coronary Stent System Sales Growth &nbsp;4.5 Europe Drug Eluting Coronary Stent System Sales Growth &nbsp;4.6 Middle East & Africa Drug Eluting Coronary Stent System Sales Growth 5 Americas &nbsp;5.1 Americas Drug Eluting Coronary Stent System Sales by Country &nbsp;5.1.1 Americas Drug Eluting Coronary Stent System Sales by Country (2021-2026) &nbsp;5.1.2 Americas Drug Eluting Coronary Stent System Revenue by Country (2021-2026) &nbsp;5.2 Americas Drug Eluting Coronary Stent System Sales by Type (2021-2026) &nbsp;5.3 Americas Drug Eluting Coronary Stent System Sales by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Drug Eluting Coronary Stent System Sales by Region &nbsp;6.1.1 APAC Drug Eluting Coronary Stent System Sales by Region (2021-2026) &nbsp;6.1.2 APAC Drug Eluting Coronary Stent System Revenue by Region (2021-2026) &nbsp;6.2 APAC Drug Eluting Coronary Stent System Sales by Type (2021-2026) &nbsp;6.3 APAC Drug Eluting Coronary Stent System Sales by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Drug Eluting Coronary Stent System by Country &nbsp;7.1.1 Europe Drug Eluting Coronary Stent System Sales by Country (2021-2026) &nbsp;7.1.2 Europe Drug Eluting Coronary Stent System Revenue by Country (2021-2026) &nbsp;7.2 Europe Drug Eluting Coronary Stent System Sales by Type (2021-2026) &nbsp;7.3 Europe Drug Eluting Coronary Stent System Sales by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Drug Eluting Coronary Stent System by Country &nbsp;8.1.1 Middle East & Africa Drug Eluting Coronary Stent System Sales by Country (2021-2026) &nbsp;8.1.2 Middle East & Africa Drug Eluting Coronary Stent System Revenue by Country (2021-2026) &nbsp;8.2 Middle East & Africa Drug Eluting Coronary Stent System Sales by Type (2021-2026) &nbsp;8.3 Middle East & Africa Drug Eluting Coronary Stent System Sales by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Drug Eluting Coronary Stent System &nbsp;10.3 Manufacturing Process Analysis of Drug Eluting Coronary Stent System &nbsp;10.4 Industry Chain Structure of Drug Eluting Coronary Stent System 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Drug Eluting Coronary Stent System Distributors &nbsp;11.3 Drug Eluting Coronary Stent System Customer 12 World Forecast Review for Drug Eluting Coronary Stent System by Geographic Region &nbsp;12.1 Global Drug Eluting Coronary Stent System Market Size Forecast by Region &nbsp;12.1.1 Global Drug Eluting Coronary Stent System Forecast by Region (2027-2032) &nbsp;12.1.2 Global Drug Eluting Coronary Stent System Annual Revenue Forecast by Region (2027-2032) &nbsp;12.2 Americas Forecast by Country (2027-2032) &nbsp;12.3 APAC Forecast by Region (2027-2032) &nbsp;12.4 Europe Forecast by Country (2027-2032) &nbsp;12.5 Middle East & Africa Forecast by Country (2027-2032) &nbsp;12.6 Global Drug Eluting Coronary Stent System Forecast by Type (2027-2032) &nbsp;12.7 Global Drug Eluting Coronary Stent System Forecast by Application (2027-2032) 13 Key Players Analysis &nbsp;13.1 Boston Scientific &nbsp;13.1.1 Boston Scientific Company Information &nbsp;13.1.2 Boston Scientific Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.1.3 Boston Scientific Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.1.4 Boston Scientific Main Business Overview &nbsp;13.1.5 Boston Scientific Latest Developments &nbsp;13.2 Medtronic &nbsp;13.2.1 Medtronic Company Information &nbsp;13.2.2 Medtronic Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.2.3 Medtronic Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.2.4 Medtronic Main Business Overview &nbsp;13.2.5 Medtronic Latest Developments &nbsp;13.3 Abbott &nbsp;13.3.1 Abbott Company Information &nbsp;13.3.2 Abbott Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.3.3 Abbott Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.3.4 Abbott Main Business Overview &nbsp;13.3.5 Abbott Latest Developments &nbsp;13.4 B.Braun &nbsp;13.4.1 B.Braun Company Information &nbsp;13.4.2 B.Braun Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.4.3 B.Braun Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.4.4 B.Braun Main Business Overview &nbsp;13.4.5 B.Braun Latest Developments &nbsp;13.5 BD &nbsp;13.5.1 BD Company Information &nbsp;13.5.2 BD Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.5.3 BD Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.5.4 BD Main Business Overview &nbsp;13.5.5 BD Latest Developments &nbsp;13.6 Biotronik AG &nbsp;13.6.1 Biotronik AG Company Information &nbsp;13.6.2 Biotronik AG Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.6.3 Biotronik AG Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.6.4 Biotronik AG Main Business Overview &nbsp;13.6.5 Biotronik AG Latest Developments &nbsp;13.7 Stentys SA &nbsp;13.7.1 Stentys SA Company Information &nbsp;13.7.2 Stentys SA Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.7.3 Stentys SA Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.7.4 Stentys SA Main Business Overview &nbsp;13.7.5 Stentys SA Latest Developments &nbsp;13.8 Sino Medical &nbsp;13.8.1 Sino Medical Company Information &nbsp;13.8.2 Sino Medical Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.8.3 Sino Medical Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.8.4 Sino Medical Main Business Overview &nbsp;13.8.5 Sino Medical Latest Developments &nbsp;13.9 Beijing ESSEN Technology &nbsp;13.9.1 Beijing ESSEN Technology Company Information &nbsp;13.9.2 Beijing ESSEN Technology Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.9.3 Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.9.4 Beijing ESSEN Technology Main Business Overview &nbsp;13.9.5 Beijing ESSEN Technology Latest Developments &nbsp;13.10 Beijing Advanced Medical Technologies &nbsp;13.10.1 Beijing Advanced Medical Technologies Company Information &nbsp;13.10.2 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.10.3 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.10.4 Beijing Advanced Medical Technologies Main Business Overview &nbsp;13.10.5 Beijing Advanced Medical Technologies Latest Developments &nbsp;13.11 LifeTech Scientific Corporation &nbsp;13.11.1 LifeTech Scientific Corporation Company Information &nbsp;13.11.2 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.11.3 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.11.4 LifeTech Scientific Corporation Main Business Overview &nbsp;13.11.5 LifeTech Scientific Corporation Latest Developments &nbsp;13.12 MicroPort Scientific Corporation &nbsp;13.12.1 MicroPort Scientific Corporation Company Information &nbsp;13.12.2 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.12.3 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.12.4 MicroPort Scientific Corporation Main Business Overview &nbsp;13.12.5 MicroPort Scientific Corporation Latest Developments &nbsp;13.13 Yilson Medical Technology &nbsp;13.13.1 Yilson Medical Technology Company Information &nbsp;13.13.2 Yilson Medical Technology Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.13.3 Yilson Medical Technology Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.13.4 Yilson Medical Technology Main Business Overview &nbsp;13.13.5 Yilson Medical Technology Latest Developments &nbsp;13.14 Lepu Medical Technology &nbsp;13.14.1 Lepu Medical Technology Company Information &nbsp;13.14.2 Lepu Medical Technology Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.14.3 Lepu Medical Technology Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.14.4 Lepu Medical Technology Main Business Overview &nbsp;13.14.5 Lepu Medical Technology Latest Developments &nbsp;13.15 Shandong Hua'an Biotechnology &nbsp;13.15.1 Shandong Hua'an Biotechnology Company Information &nbsp;13.15.2 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Product Portfolios and Specifications &nbsp;13.15.3 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.15.4 Shandong Hua'an Biotechnology Main Business Overview &nbsp;13.15.5 Shandong Hua'an Biotechnology Latest Developments 14 Research Findings and Conclusion

Report	Global Drug Eluting Coronary Stent System Market Size, Share and Opportunities 2026-2032
Selected License	Multi ID: ILR3743

Buyer Information

Order Summary